Melanocortin receptors and their accessory proteins

Molecular and Cellular Endocrinology

Volumn 331, Issue 2, 2011, Pages 215-221

  Cooray, Sadani N ^a   Clark, Adrian J L ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

MC1R; MC2R; MC3R; MC4R; MC5R; MRAP; MRAP2

Indexed keywords

ANGIOTENSIN RECEPTOR; ATTRACTIN; ATTRACTIN LIKE PROTEIN; CALCIUM SENSING RECEPTOR; CORTICOTROPIN RECEPTOR; DOPAMINE RECEPTOR; MAHOGUNIN RING FINGER 1 PROTEIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR ACCESSORY PROTEIN; MELANOCORTIN RECEPTOR ACCESSORY PROTEIN 2; MEMBRANE PROTEIN; MUSCARINIC M2 RECEPTOR; PROOPIOMELANOCORTIN; RHODOPSIN; UNCLASSIFIED DRUG;

CELL SURFACE; CELLULAR DISTRIBUTION; CHROMOSOME 6Q; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW;

ANIMALS; HUMANS; LIGANDS; MELANOCORTINS; PRO-OPIOMELANOCORTIN; RECEPTOR, MELANOCORTIN, TYPE 2; RECEPTORS, MELANOCORTIN;

EID: 78650291491     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.07.015     Document Type: Review

References (72)

1. Abdel-Malek Z.A. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol. Life Sci. 2001, 58(3):434-441.
2. Barrett P., MacDonald A., Helliwell R., Davidson G., Morgan P. Cloning and expression of a new member of the melanocyte-stimulating hormone receptor family. J. Mol. Endocrinol. 1994, 12(2):203-213.
3. Bermak J.C., Li M., Bullock C., Zhou Q.Y. Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat. Cell Biol. 2001, 3(5):492-498.
4. Boston B.A., Cone R.D. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 1996, 137(5):2043-2050.
5. Boston B.A. The role of melanocortins in adipocyte function. Ann. N. Y. Acad. Sci. 1999, 885:75-84.
6. Bouschet T., Martin S., Henley J.M. Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J. Cell Sci. 2005, 118(Pt 20):4709-4720.
7. Chambers J.C., Elliott P., Zabaneh D., Zhang W., Li Y., Froguel P., Balding D., Scott J., Kooner J.S. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat. Genet. 2008, 40(6):716-718.
8. Chan L.F., Webb T.R., Chung T.T., Meimaridou E., Cooray S.N., Guasti L., Chapple J.P., Egertova M., Elphick M.R., Cheetham M.E., Metherell L.A., Clark A.J. MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(15):6146-6151.
9. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., Rosenblum C.I., Vongs A., Feng Y., Cao L., Metzger J.M., Strack A.M., Camacho R.E., Mellin T.N., Nunes C.N., Min W., Fisher J., Gopal-Truter S., MacIntyre D.E., Chen H.Y., Van der Ploeg L.H. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000, 26(1):97-102.
10. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 1997, 91(6):789-798.
11. Chhajlani V., Wikberg J.E. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 1992, 309(3):417-420.
12. Chhajlani V., Muceniece R., Wikberg J.E. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun. 1993, 195(2):866-873.
13. Christopoulos A., Christopoulos G., Morfis M., Udawela M., Laburthe M., Couvineau A., Kuwasako K., Tilakaratne N., Sexton P.M. Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 2003, 278:3293-3297.
14. Christopoulos G., Perry K.J., Morfis M., Tilakaratne N., Gao Y., Fraser N.J., Main M.J., Foord S.M., Sexton P.M. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 1999, 56(1):235-242.
15. Clark A.J., Weber A. Adrenocorticotropin insensitivity syndromes. Endocr. Rev. 1998, 19(6):828-843.
16. Colley N.J., Baker E.K., Stamnes M.A., Zuker C.S. The cyclophilin homolog Nina A is required in the secretory pathway. Cell 1991, 67(2):255-263.
17. Cone R.D. Studies on the physiological functions of the melanocortin system. Endocr. Rev. 2006, 27(7):736-749.
18. Cooray S.N., Almiro D.V.I., Leung K.Y., Webb T.R., Chapple J.P., Egertova M., Cheetham M.E., Elphick M.R., Clark A.J. The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line. Endocrinology 2008, 149(4):1935-1941.
19. Dwyer N.D., Troemel E.R., Sengupta P., Bargmann C.I. Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein. Cell 1998, 93(3):455-466.
20. Elias L.L., Huebner A., Pullinger G.D., Mirtella A., Clark A.J. Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype. J. Clin. Endocrinol. Metab. 1999, 84(8):2766-2770.
21. Entwistle M.L., Hann L.E., Sullivan D.A., Tatro J.B. Characterization of functional melanotropin receptors in lacrimal glands of the rat. Peptides 1990, 11(3):477-483.
22. Farooqi I.S., Yeo G.S., Keogh J.M., Aminian S., Jebb S.A., Butler G., Cheetham T., O'rahilly S. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest. 2000, 106(2):271-279.
23. Ferreira P.A., Nakayama T.A., Pak W.L., Travis G.H. Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. Nature 1996, 383(6601):637-640.
24. Fraser N.J., Wise A., Brown J., McLatchie L.M., Main M.J., Foord S.M. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol. Pharmacol. 1999, 55(6):1054-1059.
25. Gantz I., Fong T.M. The melanocortin system. Am J Physiol Endocrinol Metab 2003, 284:E468-E474.
26. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 1993, 268(11):8246-8250.
27. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., DelValle J., Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 1993, 268(20):15174-15179.
28. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C.J., Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 1994, 200(3):1214-1220.
29. Gardiner K., Slavov D., Bechtel L., Davisson M. Annotation of human chromosome 21 for relevance to down syndrome: gene structure and expression analysis. Genomics 2002, 79:833-843.
30. Getting S.J., Perretti M. MC3-R as a novel target for antiinflammatory therapy. Drug News Perspect. 2000, 13(1):19-27.
31. Gimelbrant A.A., Stoss T.D., Landers T.M., McClintock T.S. Truncation releases olfactory receptors from the endoplasmic reticulum of heterologous cells. J. Neurochem. 1999, 72(6):2301-2311.
32. Griffon N., Mignon V., Facchinetti P., Diaz J., Schwartz J.C., Sokoloff P. Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 1994, 200(2):1007-1014.
33. Gu W., Tu Z., Kleyn P.W., Kissebah A., Duprat L., Lee J., Chin W., Maruti S., Deng N., Fisher S.L., Franco L.S., Burn P., Yagaloff K.A., Nathan J., Heymsfield S., Albu J., Pi-Sunyer F.X., Allison D.B. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999, 48(3):635-639.
34. Haqq A.M., Rene P., Kishi T., Khong K., Lee C.E., Liu H., Friedman J.M., Elmquist J.K., Cone R.D. Characterization of a novel binding partner of the melanocortin-4 receptor: Attractin-like protein. Biochem. J. 2003, 376(Pt 3):595-605.
35. He L., Gunn T.M., Bouley D.M., Lu X.Y., Watson S.J., Schlossman S.F., Duke-Cohan J.S., Barsh G.S. A biochemical function for Attractin in agouti-induced pigmentation and obesity. Nat. Genet. 2001, 27(1):40-47.
36. Hinney A., Schmidt A., Nottebom K., Heibult O., Becker I., Ziegler A., Gerber G., Sina M., Gorg T., Mayer H., Siegfried W., Fichter M., Remschmidt H., Hebebrand J. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 1999, 84(4):1483-1486.
37. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88(1):131-141.
38. Kuwasako K., Shimekake Y., Masuda M., Nakahara K., Yoshida T., Kitaura M., Kitamura K., Eto T., Sakata T. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J. Biol. Chem. 2000, 275(38):29602-29609.
39. Labbe O., Desarnaud F., Eggerickx D., Vassart G., Parmentier M. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 1994, 33(15):4543-4549.
40. Leclerc P.C., Auger-Messier M., Lanctot P.M., Escher E., Leduc R., Guillemette G. A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. Endocrinology 2002, 143(12):4702-4710.
41. Lein E.S., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
42. Loos R.J., Lindgren C.M., Li S., Wheeler E., Zhao J.H., Prokopenko I., Inouye M., Freathy R.M., Attwood A.P., Beckmann J.S., Berndt S.I., Jacobs K.B., Chanock S.J., Hayes R.B., Bergmann S., Bennett A.J., Bingham S.A., Bochud M., Brown M., Cauchi S., Connell J.M., Cooper C., Smith G.D., Day I., Dina C., De S., Dermitzakis E.T., Doney A.S., Elliott K.S., Elliott P., Evans D.M., Sadaf F., Froguel I., Ghori P., Groves J., Gwilliam C.J., Hadley R., Hall D., Hattersley A.S., Hebebrand A.T., Heid J., Lamina I.M., Gieger C., Illig C., Meitinger T., Wichmann T., Herrera H.E., Hinney B., Hunt A., Jarvelin S.E., Johnson M.R., Jolley T., Karpe J.D., Keniry F., Khaw A., Luben K.T., Mangino R.N., Marchini M., McArdle J., McGinnis W.L., Meyre R., Munroe D., Morris P.B., Ness A.D., Neville A.R., Nica M.J., Ong A.C., O'rahilly K.K., Owen S., Palmer K.R., Papadakis C.N., Potter K., Pouta S., Qi A., Randall L., Rayner J.C., Ring N.W., Sandhu S.M., Scherag M.S., Sims A., Song M.A., Soranzo K., Speliotes N., Syddall E.K., Teichmann H.E., Timpson S.A., Tobias N.J., Uda J.H., Vogel M., Wallace C.I., Waterworth C., Weedon D.M., Willer M.N., Wraight C.J., Yuan X., Zeggini E., Hirschhorn J.N., Strachan D.P., Ouwehand W.H., Caulfield M.J., Samani N.J., Frayling T.M., Vollenweider P., Waeber G., Mooser V., Deloukas P., McCarthy M.I., Wareham N.J., Barroso I., Jacobs K.B., Chanock S.J., Hayes R.B., Lamina C., Gieger C., Illig T., Meitinger T., Wichmann H.E., Kraft P., Hankinson S.E., Hunter D.J., Hu F.B., Lyon H.N., Voight B.F., Ridderstrale M., Groop L., Scheet P., Sanna S., Abecasis G.R., Albai G., Nagaraja R., Schlessinger D., Jackson A.U., Tuomilehto J., Collins F.S., Boehnke M., Mohlke K.L. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 2008, 40(6):768-775.
43. Martin W.J., MacIntyre D.E. Melanocortin receptors and erectile function. Eur. Urol. 2004, 45(6):706-713.
44. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393(6683):333-339.
45. Metherell L.A., Chapple J.P., Cooray S., David A., Becker C., Ruschendorf F., Naville D., Begeot M., Khoo B., Nurnberg P., Huebner A., Cheetham M.E., Clark A.J. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat. Genet. 2005, 37(2):166-170.
46. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257(5074):1248-1251.
47. Mountjoy K.G., Wild J.M. Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems. Brain Res. Dev. Brain Res. 1998, 107(2):309-314.
48. Naville D., Barjhoux L., Jaillard C., Faury D., Despert F., Esteva B., Durand P., Saez J., Begeot M. Mutations of ACTH receptor gene and familial syndrome of glucocorticoid deficiency. Ann. Endocrinol. (Paris) 1996, 57(2):101-106.
49. Perez-Oliva A.B., Olivares C., Jimenez-Cervantes C., Garcia-Borron J.C. Mahogunin ring finger-1 (MGRN1) E3 ubiquitin ligase inhibits signaling from melanocortin receptor by competition with Galphas. J. Biol. Chem. 2009, 284(46):31714-31725.
50. Rana B.K. New insights into G-protein-coupled receptor signaling from the melanocortin receptor system. Mol. Pharmacol. 2003, 64(1):1-4.
51. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.L., Simerly R.B., Cone R.D. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 1993, 90(19):8856-8860.
52. Roy S., Rached M., Gallo-Payet N. Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells. Mol. Endocrinol. 2007, 21(7):1656-1669.
53. Saito H., Kubota M., Roberts R.W., Chi Q., Matsunami H. RTP family members induce functional expression of mammalian odorant receptors. Cell 2004, 119(5):679-691.
54. Sebag J.A., Hinkle P.M. Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(51):20244-20249.
55. Sebag J.A., Hinkle P.M. Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking. J. Biol. Chem. 2009, 284(34):22641-22648.
56. Shieh B.H., Stamnes M.A., Seavello S., Harris G.L., Zuker C.S. The ninaA gene required for visual transduction in Drosophila encodes a homologue of cyclosporin A-binding protein. Nature 1989, 338:67-70.
57. Slominski A., Ermak G., Mihm M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J. Clin. Endocrinol. Metab. 1996, 81(7):2746-2749.
58. Stamnes M.A., Shieh B.H., Chuman L., Harris G.L., Zuker C.S. The cyclophilin homolog ninaA is a tissue-specific integral membrane protein required for the proper synthesis of a subset of Drosophila rhodopsins. Cell 1991, 65:219-227.
59. Star R.A., Rajora N., Huang J., Stock R.C., Catania A., Lipton J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. U.S.A. 1995, 92(17):8016-8020.
60. Starowicz K., Przewlocka B. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci. 2003, 73(7):823-847.
61. Taylor A., Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol. Cell Biol. 2001, 79(4):358-367.
62. Vaisse C., Clement K., Guy-Grand B., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 1998, 20(2):113-114.
63. Viklund H., Elofsson A. Best alpha-helical transmembrane protein topology predictions are achieved using hidden Markov models and evolutionary information. Protein Sci. 2004, 13:1908-1917.
64. Wangensteen T., Kolsgaard M.L., Mattingsdal M., Joner G., Tonstad S., Undlien D., Retterstol L. Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway. Exp. Clin. Endocrinol. Diabetes 2009, 117(6):266-273.
65. Webb T.R., Chan L., Cooray S.N., Cheetham M.E., Chapple J.P., Clark A.J. Distinct melanocortin 2 receptor accessory protein domains are required for melanocortin 2 receptor interaction and promotion of receptor trafficking. Endocrinology 2009, 150(2):720-726.
66. Webb T.R., Clark A.J. Minireview: the melanocortin 2 receptor accessory proteins. Mol. Endocrinol. 2010, 24:475-484.
67. Weber A., Kapas S., Hinson J., Grant D.B., Grossman A., Clark A.J. Functional characterization of the cloned human ACTH receptor: impaired responsiveness of a mutant receptor in familial glucocorticoid deficiency. Biochem. Biophys. Res. Commun. 1993, 197(1):172-178.
68. Wikberg J.E., Muceniece R., Mandrika I., Prusis P., Lindblom J., Post C., Skottner A. New aspects on the melanocortins and their receptors. Pharmacol. Res. 2000, 42(5):393-420.
69. Xia Y., Wikberg J.E., Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 1995, 6(16):2193-2196.
70. Xu A., Choi K.L., Wang Y., Permana P.A., Xu L.Y., Bogardus C., Cooper G.J. Identification of novel putative membrane proteins selectively expressed during adipose conversion of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 2002, 293(4):1161-1167.
71. Yang Y.K., Ollmann M.M., Wilson B.D., Dickinson C., Yamada T., Barsh G.S., Gantz I. Effects of recombinant agouti-signaling protein on melanocortin action. Mol. Endocrinol. 1997, 11(3):274-280.
72. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., O'rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 1998, 20(2):111-112.